Why MedTech Must Solve Data Silos Before Implementing Agentic AI

1. Key Takeaways

• MedTech agentic AI requires authoritative, version-aware, traceable data across product, quality, regulatory, manufacturing, and service systems.
• Fragmented MedTech data creates incomplete context, conflicting records, broken identity matching, temporal errors, and weak auditability for AI outputs.
• MedTech companies are not ready for agentic AI without canonical entities, source-of-truth rules, workflow controls, and human oversight.

MedTech companies are moving beyond AI tools that summarize documents or answer questions. The focus is now shifting toward systems that can classify events, assemble evidence, route work, and support decisions across quality, regulatory, service, and commercial operations. That shift is attractive because it promises leverage in areas where skilled labor is limited, and process friction is expensive. It also raises the bar for what the underlying data environment must support.

In MedTech, agentic AI does not fail first because the model is weak. It fails because the system is asked to operate on fragmented, inconsistent, and weakly governed enterprise data. A narrow pilot can look effective when the source set is curated and an expert is watching closely. Real workflows are different. They depend on version history, source authority, traceability, and cross-functional context that most organizations still struggle to unify.

 

The Shift From Assistance to Delegation

MedTech organizations are moving from AI systems that support individual tasks toward systems that carry part of the workflow itself. That shift changes the standard for data quality because an agent must do more than retrieve information. It must identify the next step, determine which evidence is relevant, apply workflow rules, preserve context, and produce a recommendation or action that can influence downstream execution.

A copilot can remain useful when information is incomplete because the user can notice missing context and compensate. An agentic system has less room for ambiguity. Once it is expected to classify complaints, support CAPA activity, assemble regulatory evidence, or trigger service actions, the quality of the enterprise context becomes a direct control issue.

The responsibility ladder

Predictive AI
Produces a narrow score, forecast, or classification.

↓

Copilot AI
Supports a user who remains responsible for context, judgment, and next steps.

↓

Agentic AI
Carries part of the workflow and maintains context across multiple steps.

↓

Controlled agentic execution
Operates within defined evidence, authority, approval, monitoring, and change-control boundaries.

 

The MedTech Silo Stack

The MedTech silo problem is often described as disconnected software platforms, but the issue is broader. Data fragmentation exists across functions, systems, terminology, governance, and time. These layers interact, which means technical integration alone cannot provide the coherent context an agentic system needs.

An organization may connect eQMS, PLM, ERP, MES, CRM, service, telemetry, and document repositories while still leaving product identity, source authority, approval status, and historical applicability unresolved. The result is a connected environment that remains difficult for an AI system to interpret reliably.

The layered silo model

Layer 4: Governance silos

Ownership, source authority, stewardship, access rights, and approval rules are inconsistent or not machine-readable.

Layer 3: Semantic silos

Product codes, event categories, document types, customer identifiers, and quality terms do not carry the same meaning across functions.

Layer 2: System silos

Records are distributed across specialized platforms with different structures, controls, and update cycles.

Layer 1: Functional silos

R&D, quality, regulatory, clinical, manufacturing, service, and commercial teams each own part of the lifecycle truth.

 

Agentic AI fails when these layers are treated as separate integration problems. Technical connectivity may solve the system layer while leaving meaning, authority, and historical context unresolved.

 

How Data Silos Break Agentic AI

The failure is usually plausible, not obvious

The first failure mode is incomplete context. An agent may retrieve a complaint narrative but miss the service history, lot traceability, prior field actions, or the document version that applied when the event occurred. The output may still look polished, but it is built on an incomplete state. In MedTech, that affects classification, escalation, and evidence quality in workflows that already carry regulatory and quality implications.

The second failure mode is conflicting source authority. One system may govern product master data, another complaint records, another shipment history, and another approved labeling. If those authority rules are not explicit, the agent cannot know which source controls which fact. Broken identity resolution makes that even harder. The system may not be able to determine whether two records refer to the same lot, site, customer, or device.

 

 

A hallucinated statement may be easier to detect because it is clearly unsupported. Mis-contextualized execution is more dangerous because the recommendation may be factually grounded in real records while still being wrong for the specific device, lot, site, customer, or point in time.

 

For agentic AI, access to more data is not enough. The system must know which data is authoritative, how records relate, and what was true at the relevant time.

Why this is a MedTech-specific problem

Many AI discussions focus on hallucination. In MedTech, the more dangerous issue is mis-contextualized execution. The system may produce a reasonable recommendation based on incomplete or non-authoritative enterprise data. That is harder to catch than an obviously fabricated answer and more damaging in practice.

This is why silo reduction is not just a data-quality initiative. It is a control requirement. If the enterprise cannot replay the evidence chain behind an output, then validation becomes weak, auditability declines, and trust erodes quickly. Teams then compensate by narrowing the use case and increasing manual review, which strips away much of the value that agentic AI was supposed to deliver.

 

The Minimum AI-Serving Foundation

Solving data silos does not require moving every record into one central repository. It requires an AI-serving data layer that preserves source ownership while making critical identities, relationships, versions, and authority rules available for trusted workflow use.

The foundation must allow the system to determine what a record represents, whether it is authoritative, when it was effective, how it relates to other records, and whether the user or agent is permitted to act on it.

Five required capabilities

 

Implementation checklist

1. Critical entities can be reconciled across systems.
2. Each critical attribute has a declared authoritative source.
3. Historical states can be reconstructed accurately.
4. AI outputs can be traced to exact records and versions.
5. Terminology is standardized across major operating functions.
6. Permissions distinguish viewing, drafting, recommending, approving, and executing.
7. Retrieval failures, overrides, exceptions, and escalations are logged.
8. Conflicting values are resolved through defined rules rather than ad hoc judgment.

 

The Delegation Envelope

The appropriate objective for MedTech is not broad AI autonomy. It is controlled delegation within bounded workflows. An agent should operate only where task scope, source sets, permissions, approval points, and exception handling have been explicitly defined.

This operating model allows organizations to measure retrieval quality, override frequency, exception rates, escalation patterns, and downstream outcomes. It also creates a clear basis for validation, monitoring, and controlled expansion.

 

Five boundaries around the agent

1. Task boundary

Defines the workflow the agent may enter, the conditions that trigger it, and the point at which the task is complete.

2. Evidence boundary 

Which systems, records, versions, and data classes the agent may use.

3. Authority boundary

Defines whether the agent may view, draft, recommend, approve, route, or execute.

4. Human boundary

Where review, approval, exception handling, and accountability remain mandatory.

5. Change boundary

How prompts, rules, models, connectors, source sets, and decision logic are governed.

Controlled delegation is not a limitation on agentic AI. It is the mechanism that makes agentic AI measurable, governable, and defensible in regulated workflows.

 

Interoperability Helps, but It Does Not Solve the Whole Problem

Interoperability enables systems to exchange data, but it does not guarantee that the combined information is coherent. An agent may have access to multiple repositories and still be unable to determine which product hierarchy is current, which complaint taxonomy governs, or which document version applied on the relevant date.

Operational coherence requires more than technical access. It requires shared meaning, identity resolution, source ranking, temporal logic, policy-aware retrieval, and replayable evidence.

Connectivity compared with coherence

 

Interoperability allows systems to communicate. Operational coherence allows an agent to determine what a record means, whether it applies, and whether it can support action.

 

Agentic AI Readiness Scorecard

A readiness assessment should test whether the enterprise context can support controlled delegation, not merely whether an AI model performs well in a curated pilot. Each area should be evaluated against actual workflow behavior rather than stated policy.

Score each category from 0 to 2:

• 0: not defined
• 1: partially defined or manually managed
• 2: governed, repeatable, and observable

 

Readiness interpretation

13 to 16 points

The organization may be ready for bounded agentic workflows with formal validation, monitoring, and human approval at defined control points.

8 to 12 points

The organization should limit deployment to advisory use cases with strong human review while strengthening data and governance controls.

0 to 7 points 

The organization is likely to reproduce existing silo problems through a more powerful interface. Investment should remain focused on data coherence, source authority, and workflow control.

 

Final Principle

The MedTech organizations most likely to create value from agentic AI are not necessarily those running the most pilots. They are the organizations with the clearest source authority, strongest identity model, most reliable historical context, and most disciplined delegation controls.

Before a MedTech organization asks an agent to act, it must be able to prove that the enterprise context is trustworthy enough to support the action.

 

Why We Built Enlil for This Challenge

At Enlil, we see this as a data and workflow problem before it is an AI problem. MedTech teams cannot rely on agentic systems if product, quality, manufacturing, and regulatory information remain fragmented across disconnected tools and handoffs. That is why we built Enlil as a unified development traceability platform for the MedTech ecosystem, giving regulated teams a connected foundation for decisions that need context, control, and traceability.

We have also built agentic AI for the development lifecycle around that same foundation, so AI can operate within the reality of MedTech workflows rather than outside them. By combining unified data, domain-specific intelligence, and workflow-aware execution, we help teams reduce fragmentation and improve how they manage development, compliance, and submissions. For organizations evaluating where AI can create real value, the more important question is whether the underlying system is ready to support it.